Lelantos Holdings, Inc. Achieves OTC Level 2 Quotation and Improved Disclosure Service Approval
Lelantos Holdings, Inc. (OTC PINK: LNTO) has qualified for OTC Level 2 quotations and been approved for the Improved Disclosure Service, marking significant steps towards enhanced market transparency and investor trust.
Lelantos Holdings, Inc. (OTC PINK: LNTO) has reached a significant milestone by qualifying for OTC Level 2 quotations on the OTC Markets platform, a development that enhances real-time trading visibility and market transparency for investors. This level of access provides detailed bid and ask data across all market makers, offering a deeper insight into stock activity. Nathan Puente, CEO of Lelantos Holdings, described this achievement as a key step in the company's capital markets strategy.
In addition to gaining OTC Level 2 quotations, Lelantos Holdings has also received approval to join OTC Markets' Improved Disclosure Service starting July 2025. Joshua Weaver, COO of the company, stated that this move reflects Lelantos' commitment to transparency, regulatory alignment, and the building of long-term investor trust. These developments are pivotal for the company as it seeks to strengthen its position in the market and enhance its appeal to investors.
For more details on this announcement, visit https://ibn.fm/3lrgA.